1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Cancer Prevention and Research Institute of Texas (CPRIT) Academic Research is sponsored by Cancer Prevention and Research Institute of Texas (CPRIT). CPRIT funds groundbreaking studies at universities and research institutions across Texas making critical advances against cancer. They award merit-based grants through three programs: Academic Research, Prevention, and Product Development Research.
Get alerted about grants like this
Get emailed when new opportunities from “Cancer Prevention and Research Institute of Texas (CPRIT)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
March 31, 2026 Baylor College of Medicine Unexpected cancer vulnerability points at potential novel treatments The future of cancer research may lie in tricking the immune system, UT researchers say April 6, 2026 The University of Texas at San Antonio Health Research Challenge provides funding to integrated teams to address critical health challenges April 7, 2026 Baylor College of Medicine Uncovering the driving force behind lethal infant brain tumor April 8, 2026 The University of Texas in Austin Celebration of Research: 5 Faculty Members Honored for Transformative Contributions April 8, 2026 The University of Texas MD Anderson Cancer Center Study identifies strategy to overcome radiation therapy resistance in lung cancer April 8, 2026 The University of Texas MD Anderson Cancer Center Researchers find new target to sensitize pancreatic tumors to immunotherapy April 7, 2026 Oregon Health & Science University OHSU expands clinical trial to prevent cancer in rare genetic condition April 8, 2026 Plus Therapeutics, Inc. Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ in Pediatric Malignant Gliomas April 9, 2026 Baylor College of Medicine FROM THE LABS: How does ZR make cancer happen?
Locking brain development in immature state can drive tumor growth April 9, 2026 The University of Texas MD Anderson Cancer Center 3 reasons appendix cancer is hard to diagnose April 10, 2026 Baylor College of Medicine Blog Network Uncovering the driving force behind lethal infant brain tumor April 13, 2026 The University of Texas MD Anderson Cancer Center AACR: Immunotherapy pioneer James P. Allison, Ph. D.
, honored with Award for Lifetime Achievement in Cancer Research April 13, 2026 The University of Texas MD Anderson Cancer Center AACR: Jennifer Wargo, M. D.
, elected Fellow of the AACR Academy April 14, 2026 The University of Texas Southwestern Medical Center Liu named Sloan Research Fellow in Neuroscience NIH-funded breakthrough shrinks CRISPR for precision delivery in the body April 14, 2026 The University of Texas at Austin New Bite-sized CRISPR Molecule May Open Doors for Therapeutic Genome Editing April 14, 2026 Business Wire CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates April 14, 2026 ImmunoGenesis BostonGene and ImmunoGenesis Announce Strategic Partnership to Overcome Immunotherapy Resistance April 14, 2026 Iterion Therapeutics Iterion Presents New Data on First-in-Class TBL1 Inhibitor Tegavivint, Targeting Wnt-Driven Cancers at AACR Annual Meeting April 15, 2026 Texas Medical Center Texas Medical Center Venture Fund Announces Acquisition of CrossBridge Bio for $300 Million by Eli Lilly April 15, 2026 Greater Houston Partnership Eli Lilly to Acquire Houston Biotech Startup CrossBridge Bio April 15, 2026 The University of Texas Health Science Center at Houston UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation April 15, 2026 Rice University Rice bioengineer to lead national organization, advocate for research funding on Capitol Hill April 16, 2026 UT MD Anderson Newswise First-Line Targeted Therapy Shows Antitumor Activity in Patients with Advanced Lung Cancer April 16, 2026 UT MD Anderson Cancerwise Blog Top 3 UT MD Anderson abstracts at AACR 2026 April 17, 2026 Rice University Engineered dual-bacterial sensors turn chemical signals into electricity April 17, 2026 The University of Texas MD Anderson Cancer Center First-line targeted therapy shows antitumor activity in patients with advanced lung cancer April 20, 2026 The University of Texas MD Anderson Cancer Center AACR: Clinical trial presentations feature advances across cancer care April 20, 2026 The University of Texas Southwestern Medical Center UT Southwestern biochemist Zhijian James Chen receives 2026 Japan Prize April 21, 2026 The University of Texas at Austin Transforming Cancer Treatment Through Digital Innovation April 21, 2026 The University of Texas MD Anderson Cancer Center AACR: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous oral lesions April 21, 2026 American Association for Cancer Research Intralesional Nivolumab May Be Effective Against Precancerous Oral Lesions April 21, 2026 Medicenna Therapeutics Corp. Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026 April 21, 2026 Salud America!
San Antonio, Get Help Quitting Smoking with the Quitxt Study!
Implementing Subcutaneous Amivantamab in Clinical Practice for EGFR+ NSCLC April 23, 2026 Baylor College of Medicine New method reveals structures of RNA-protein complexes in living cells April 23, 2026 The University of Texas MD Anderson Cancer Center When to see a dermatologist about a skin change April 23, 2026 The University of Texas MD Anderson Cancer Center Novel tool more accurately predicts risk of Li-Fraumeni Syndrome Curtana Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for CT-179 in Pediatric High-Grade Glioma AACR Announces Recipients of AACR Trailblazer Cancer Research Grants 2026 'It's incredible, like science fiction': How a new wave of immunotherapy is eliminating cancers April 23, 2026 UT Health San Antonio UT San Antonio-led cancer research program could revolutionize treatment April 27, 2026 Rice University 8 Big Questions Rice Is Asking About the Brain April 27, 2026 The University of Texas MD Anderson Cancer Center Imaging tool reveals novel insights into DNA replication stress response April 28, 2026 Rice University Rice Biotech Launch Pad receives award for research to advance cell-based therapy for Type 1 diabetes April 28, 2026 The University of Texas MD Anderson Cancer Center UT MD Anderson establishes Center for Cellular Language Intelligence with $10 million gift from Peggy and Carl Sewell April 28, 2026 The University of Texas MD Anderson Cancer Center Breast cancer risk assessments: What to know April 28, 2026 The University of Texas Southwestern Medical Center UT Southwestern molecular biologist Kim Orth, Ph.
D.
, elected to American Academy of Arts and Sciences April 29, 2026 Texas A&M University Coffee doesn t just wake you up it may help protect your body from aging April 28, 2026 The University of Texas Southwestern Medical Center Three UT Southwestern faculty members elected to National Academy of Sciences April 29, 2026 The University of Texas MD Anderson Cancer Center Researchers identify how enzyme affects infertility and cancer progression April 30, 2026 Rice University Student-founded Bionostic wins Rice Launch Challenge April 30, 2026 The University of Texas Health Science Center at Houston Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments, UTHealth Houston researchers find April 30, 2026 The University of Texas Southwestern Medical Center Cell maturity determines pyrimidine synthesis pathway preference April 29, 2026 Houston.
Innovationmap. com New 'living pharmacy' biotech company launches out of Rice venture studio
According to the current listing, eligibility includes: Universities and research institutions across Texas. Confirm the full requirements in the official notice before applying.
The current listing shows varies, over $103 million in grants awarded in recent cycle. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Cancer Prevention and Research Institute of Texas (CPRIT) Academic Research is funded by Cancer Prevention and Research Institute of Texas (CPRIT). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Texas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The August 31, 2026 award announcement splits $77 million across ten programs — $22.2 million to prevention, $23.6 million to treatment and recovery, $21.8 million to community mental health, $9.4 million to suicide and crisis. Read against the proposed consolidation of SAMHSA into the Administration for a Healthy America, the breakdown is a priorities map.
Read articleThe FY2026 COPS School Violence Prevention Program offers up to $500,000 per award across roughly 200 grants, with a 25% match and a $100,000 microgrant lane for rural and tribal schools. But the statute limits it to physical security and law enforcement coordination — not mental health. Here is what SVPP actually funds, who can apply, and how to build a competitive application before August 4, 2026.
Read articleOn June 24, 2026, FEMA released more than $1.5 billion across the Homeland Security Grant Program, a $300 million Nonprofit Security Grant Program, and six infrastructure-protection programs — all with an application window closing around July 24. This is the definitive breakdown: how SHSP, UASI, Operation Stonegarden, and the transit, port, Amtrak, and intercity-bus grants differ, what the new FY2026 priorities signal, why almost none of the money comes to you directly from FEMA, and the strategy for competing through your State Administrative Agency.
Read article